Usefulness of semi-automatic harmonization strategy of standardized uptake values for multicenter PET studies
暂无分享,去创建一个
Tadashi Watabe | Mana Ishibashi | Kimiteru Ito | Hiromitsu Daisaki | Kazuhiro Kitajima | Masatoyo Nakajo | Fumi Sakamoto | Tadaki Nakahara | Akira Toriihara | T. Watabe | K. Kitajima | H. Daisaki | T. Nakahara | F. Sakamoto | A. Toriihara | Kimiteru Ito | M. Nakajo | M. Ishibashi | Akira Toriihara | Fumi Sakamoto
[1] Elena Prieto,et al. Impact of Time-of-Flight and Point-Spread-Function in SUV Quantification for Oncological PET , 2013, Clinical nuclear medicine.
[2] K. Akashi,et al. Standardization of image quality across multiple centers by optimization of acquisition and reconstruction parameters with interim FDG-PET/CT for evaluating diffuse large B cell lymphoma , 2013, Annals of Nuclear Medicine.
[3] A. Kuten,et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] N. Aide,et al. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[5] N. Obuchowski,et al. The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy. , 2020, Radiology.
[6] Jeong Won Lee,et al. 18F-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study , 2017, The Journal of Nuclear Medicine.
[7] R. Boellaard,et al. Quantitative implications of the updated EARL 2019 PET–CT performance standards , 2019, EJNMMI Physics.
[8] W. Oyen,et al. EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[9] R. Boellaard,et al. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[10] D. Binns,et al. Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[11] Eric J. W. Visser,et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[12] P. Christian,et al. Quantitative PET/CT Scanner Performance Characterization Based Upon the Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network Oncology Clinical Simulator Phantom , 2015, The Journal of Nuclear Medicine.
[13] Martin A Lodge,et al. Noise Considerations for PET Quantification Using Maximum and Peak Standardized Uptake Value , 2012, The Journal of Nuclear Medicine.
[14] D. Binns,et al. Does PET SUV Harmonization Affect PERCIST Response Classification? , 2016, The Journal of Nuclear Medicine.
[15] M. Senda,et al. Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 2.0 , 2014, Annals of Nuclear Medicine.
[16] Ronald Boellaard,et al. Mutatis Mutandis: Harmonize the Standard! , 2012, The Journal of Nuclear Medicine.
[17] Yuji Tsutsui,et al. Multicentre analysis of PET SUV using vendor-neutral software: the Japanese Harmonization Technology (J-Hart) study , 2018, EJNMMI Research.
[18] Robert Jeraj,et al. Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response , 2012, The Journal of Nuclear Medicine.
[19] Martin A Lodge,et al. Feasibility of state of the art PET/CT systems performance harmonisation , 2018, European Journal of Nuclear Medicine and Molecular Imaging.
[20] Marc Kachelriess,et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] Giuseppe Esposito,et al. Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease , 2017, The Journal of Nuclear Medicine.